jRCT2031220536已完成不适用
Pharmacokinetic study of HP-6050
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- All
入选标准
- •Healthy Japanese adults aged >=18 and <65 years, or healthy Japanese elderly aged >=65 years (at the time of informed consent)
排除标准
- •Subjects with current or history of serious cardiac, vascular, renal, hepatic, psychiatric/neurological, or metabolic diseases
- •Subjects who received any drug within a week prior to application of the study drug
结局指标
主要结局
-
Pharmacokinetic parameters, adverse events
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
Pharmacokinetic study of HP-6050Healthy adult and elderlyJPRN-jRCT2031220536Inakura Hiroshi60
招募中
不适用
Pharmacokinetic study of HP-6050 - Investigation of application site -jRCT2031240538Hisamitsu Pharmaceutical Co., Inc.15
招募中
不适用
Pharmacokinetic study of HP-5120jRCT2031240331Hisamitsu Pharmaceutical Co., Inc.112
已完成
2 期
Single dose pharmacokinetic study of HP-3060Allergic rhinitisJPRN-jRCT2080223788Hisamitsu Pharmaceutical Co., Inc.24
未知
2 期
Single dose pharmacokinetic study of HP-3060Allergic rhinitisJPRN-jRCT2080223009Hisamitsu Pharmaceutical Co., Inc.